Literature DB >> 24632289

Keep-ING balance: tumor suppression by epigenetic regulation.

Gesche Tallen1, Karl Riabowol2.   

Abstract

Cancer cells accumulate genetic and epigenetic changes that alter gene expression to drive tumorigenesis. Epigenetic silencing of tumor suppressor, cell cycle, differentiation and DNA repair genes contributes to neoplastic transformation. The ING (inhibitor of growth) proteins (ING1-ING5) have emerged as a versatile family of growth regulators, phospholipid effectors, histone mark sensors and core components of HDAC1/2 - and several HAT chromatin-modifying complexes. This review will describe the characteristic pathways by which ING family proteins differentially affect the Hallmarks of Cancer and highlight the various epigenetic mechanisms by which they regulate gene expression. Finally, we will discuss their potentials as biomarkers and therapeutic targets in epigenetic treatment strategies.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epigenetic cancer therapy; Epigenetic regulation; ING-protein; Tumor suppression

Mesh:

Substances:

Year:  2014        PMID: 24632289     DOI: 10.1016/j.febslet.2014.03.011

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

Review 1.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

2.  Molecular Insights into Inhibition of the Methylated Histone-Plant Homeodomain Complexes by Calixarenes.

Authors:  Muzaffar Ali; Kevin D Daze; Daniel E Strongin; Scott B Rothbart; Hector Rincon-Arano; Hillary F Allen; Janessa Li; Brian D Strahl; Fraser Hof; Tatiana G Kutateladze
Journal:  J Biol Chem       Date:  2015-07-30       Impact factor: 5.157

3.  Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancer.

Authors:  H Zhang; X Zhou; C Xu; J Yang; J Xiang; M Tao; Y Xie
Journal:  Cancer Gene Ther       Date:  2015-11-13       Impact factor: 5.987

4.  Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer.

Authors:  Huimeng Li; Hengyu Zhang; Xin Tan; Dequan Liu; Rong Guo; Maohua Wang; Yiyin Tang; Kai Zheng; Wenlin Chen; Hongwan Li; Mingjian Tan; Ke Wang; Rui Liu; Shicong Tang
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

5.  ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.

Authors:  Ulrike Linzen; Richard Lilischkis; Ruwin Pandithage; Britta Schilling; Andrea Ullius; Juliane Lüscher-Firzlaff; Elisabeth Kremmer; Bernhard Lüscher; Jörg Vervoorts
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

6.  Maintenance of leukemia-initiating cells is regulated by the CDK inhibitor Inca1.

Authors:  Nicole Bäumer; Sebastian Bäumer; Frank Berkenfeld; Martin Stehling; Gabriele Köhler; Wolfgang E Berdel; Carsten Müller-Tidow; Petra Tschanter
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

7.  Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.

Authors:  A Boyko; K Riabowol
Journal:  Cell Death Discov       Date:  2015-10-26

8.  SCFJFK is functionally linked to obesity and metabolic syndrome.

Authors:  Lin He; Ruorong Yan; Ziran Yang; Yue Zhang; Xinhua Liu; Jianguo Yang; Xujun Liu; Xiaoping Liu; Lu Xia; Yue Wang; Jiajing Wu; Xiaodi Wu; Lin Shan; Xiaohan Yang; Jing Liang; Yongfeng Shang; Luyang Sun
Journal:  EMBO Rep       Date:  2021-06-11       Impact factor: 9.071

Review 9.  Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer.

Authors:  Ran Zhao; Bu Young Choi; Mee-Hyun Lee; Ann M Bode; Zigang Dong
Journal:  EBioMedicine       Date:  2016-05-03       Impact factor: 8.143

10.  Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3.

Authors:  Sophia Kim; Senthil Natesan; Gabriel Cornilescu; Samuel Carlson; Marco Tonelli; Urszula L McClurg; Olivier Binda; Craig N Robson; John L Markley; Stefan Balaz; Karen C Glass
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.